Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Amortization - IntangiblesConsolidated Net IncomeCost of RevenueDepreciation & Amortization - TotalEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Verastem (VSTM) Operating Expenses (2018 - 2025)

Verastem has reported Operating Expenses over the past 8 years, most recently at $59.0 million for Q4 2025.

  • Quarterly results put Operating Expenses at $59.0 million for Q4 2025, up 86.8% from a year ago — trailing twelve months through Dec 2025 was $201.0 million (up 60.89% YoY), and the annual figure for FY2025 was $201.0 million, up 60.89%.
  • Operating Expenses for Q4 2025 was $59.0 million at Verastem, up from $52.0 million in the prior quarter.
  • Over the last five years, Operating Expenses for VSTM hit a ceiling of $59.0 million in Q4 2025 and a floor of $14.8 million in Q3 2021.
  • Median Operating Expenses over the past 5 years was $21.4 million (2022), compared with a mean of $27.9 million.
  • Biggest five-year swings in Operating Expenses: plummeted 76.67% in 2021 and later surged 86.8% in 2025.
  • Verastem's Operating Expenses stood at $17.1 million in 2021, then decreased by 1.23% to $16.8 million in 2022, then soared by 84.85% to $31.1 million in 2023, then increased by 1.45% to $31.6 million in 2024, then surged by 86.8% to $59.0 million in 2025.
  • The last three reported values for Operating Expenses were $59.0 million (Q4 2025), $52.0 million (Q3 2025), and $45.9 million (Q2 2025) per Business Quant data.